This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here
Fartusomin
Name of the project:
FARTUSOMIN: Development of biological drugs against CCR9 in solid tumours through the modulation of the immune system of the patient (RTC-2017-6131-1).
Partners:
Funding instrument:
Funding agent:
